Year |
Citation |
Score |
2023 |
Bose RJ, Kumar SU, Zeng Y, Afjei R, Robinson E, Lau K, Bermudez A, Habte F, Pitteri SJ, Sinclair R, Willmann JK, Massoud TF, Gambhir SS, Paulmurugan R. Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents". Acs Nano. PMID 37721437 DOI: 10.1021/acsnano.3c08363 |
0.761 |
|
2023 |
Sukumar UK, Rajendran JCB, Gambhir SS, Massoud TF, Paulmurugan R. Correction to "SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo". Acs Applied Materials & Interfaces. PMID 37605509 DOI: 10.1021/acsami.3c09905 |
0.567 |
|
2023 |
Kumar US, Afjei R, Ferrara K, Massoud TF, Paulmurugan R. Correction to "Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle". Acs Nano. PMID 37582219 DOI: 10.1021/acsnano.3c07103 |
0.428 |
|
2022 |
Afjei R, Sadeghipour N, Kumar SU, Pandrala M, Kumar V, Malhotra SV, Massoud TF, Paulmurugan R. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers. 14. PMID 36551609 DOI: 10.3390/cancers14246120 |
0.513 |
|
2022 |
Liu Y, Sukumar UK, Jugniot N, Seetharam SM, Rengaramachandran A, Sadeghipour N, Mukherjee P, Krishnan A, Massoud TF, Paulmurugan R. Inhaled Gold Nano-star Carriers for Targeted Delivery of Triple Suicide Gene Therapy and Therapeutic MicroRNAs to Lung Metastases: Development and Validation in a Small Animal Model. Advanced Therapeutics. 5. PMID 36212523 DOI: 10.1002/adtp.202200018 |
0.502 |
|
2022 |
Paulmurugan R, Liu Y, Sukumar UK, Kanada M, Massoud TF. BRET Sensors for Imaging Membrane Integrity of Microfluidically Generated Extracellular Vesicles. Methods in Molecular Biology (Clifton, N.J.). 2525: 227-238. PMID 35836072 DOI: 10.1007/978-1-0716-2473-9_17 |
0.499 |
|
2022 |
Sadeghipour N, Kumar SU, Massoud TF, Paulmurugan R. A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models. Scientific Reports. 12: 12017. PMID 35835978 DOI: 10.1038/s41598-022-16219-x |
0.476 |
|
2022 |
Jugniot N, Massoud TF, Dahl JJ, Paulmurugan R. Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging. Journal of Nanobiotechnology. 20: 267. PMID 35689262 DOI: 10.1186/s12951-022-01484-9 |
0.563 |
|
2022 |
Paulmurugan R, Malhotra M, Massoud ZT, Massoud TF. Correction to: The protean world of non-coding RNAs in glioblastoma. Journal of Molecular Medicine (Berlin, Germany). 100: 1093. PMID 35648188 DOI: 10.1007/s00109-022-02211-5 |
0.399 |
|
2022 |
Kumar US, Natarajan A, Massoud TF, Paulmurugan R. FN3 linked nanobubbles as a targeted contrast agent for US imaging of cancer-associated human PD-L1. Journal of Controlled Release : Official Journal of the Controlled Release Society. 346: 317-327. PMID 35469983 DOI: 10.1016/j.jconrel.2022.04.030 |
0.521 |
|
2021 |
Liu Y, Sukumar UK, Kanada M, Krishnan A, Massoud TF, Paulmurugan R. Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin. Advanced Functional Materials. 31. PMID 34899115 DOI: 10.1002/adfm.202103600 |
0.507 |
|
2021 |
Bose RJ, Kumar US, Garcia-Marques F, Zeng Y, Habte F, McCarthy JR, Pitteri S, Massoud TF, Paulmurugan R. Engineered Cell-Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple-Negative Breast Cancer in Mice. Advanced Healthcare Materials. e2101387. PMID 34879180 DOI: 10.1002/adhm.202101387 |
0.538 |
|
2021 |
Wang K, Kumar US, Sadeghipour N, Massoud TF, Paulmurugan R. A Microfluidics-Based Scalable Approach to Generate Extracellular Vesicles with Enhanced Therapeutic MicroRNA Loading for Intranasal Delivery to Mouse Glioblastomas. Acs Nano. PMID 34723509 DOI: 10.1021/acsnano.1c07587 |
0.473 |
|
2021 |
Kumar US, Afjei R, Ferrara K, Massoud TF, Paulmurugan R. Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle. Acs Nano. PMID 34705425 DOI: 10.1021/acsnano.1c05002 |
0.452 |
|
2021 |
Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, ... ... Massoud TF, et al. A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475101 DOI: 10.1158/1078-0432.CCR-21-0544 |
0.752 |
|
2021 |
Sukumar UK, Habte F, Massoud TF, Paulmurugan R. High-Throughput Whole-Plate Imaging of Cells for Multiple Biological Applications. Methods in Molecular Biology (Clifton, N.J.). 2274: 367-384. PMID 34050486 DOI: 10.1007/978-1-0716-1258-3_30 |
0.553 |
|
2020 |
Liu Y, Wang K, Massoud TF, Paulmurugan R. SARS-CoV-2 Vaccine Development: An Overview and Perspectives. Acs Pharmacology & Translational Science. 3: 844-858. PMID 33062951 DOI: 10.1021/acsptsci.0c00109 |
0.427 |
|
2020 |
Bose RJ, Tharmalingam N, Garcia Marques FJ, Sukumar UK, Natarajan A, Zeng Y, Robinson E, Bermudez A, Chang E, Habte F, Pitteri SJ, McCarthy J, Gambhir SS, Massoud TF, Mylonakis E, et al. Reconstructed Apoptotic Bodies as Targeted 'Nano Decoys' to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells. Acs Nano. PMID 32347709 DOI: 10.1021/Acsnano.0C00921 |
0.584 |
|
2020 |
Kim SB, Hori SS, Sadeghipour N, Sukumar UK, Fujii R, Massoud TF, Paulmurugan R. Highly sensitive eight-channel light sensing system for biomedical applications. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. PMID 32159572 DOI: 10.1039/D0Pp00017E |
0.764 |
|
2020 |
Sukumar UK, Rajendran JCB, Gambhir SS, Massoud TF, Paulmurugan R. SP94-Targeted Triblock Co-Polymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in vivo. Acs Applied Materials & Interfaces. PMID 32048820 DOI: 10.1021/Acsami.9B20071 |
0.601 |
|
2019 |
Bae Kim S, Fujii R, Natarajan A, Massoud TF, Paulmurugan R. Ligand-activated BRET9 imaging for measuring protein-protein interactions in living mice. Chemical Communications (Cambridge, England). PMID 31807738 DOI: 10.1039/C9Cc07634D |
0.522 |
|
2019 |
Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, Zeng Y, Chang E, Habte F, Sinclair R, Gambhir SS, Massoud TF, Paulmurugan R. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials. 218: 119342. PMID 31326657 DOI: 10.1016/J.Biomaterials.2019.119342 |
0.611 |
|
2019 |
Paulmurugan R, Malhotra M, Massoud TF. The protean world of non-coding RNAs in glioblastoma. Journal of Molecular Medicine (Berlin, Germany). PMID 31129756 DOI: 10.1007/S00109-019-01798-6 |
0.48 |
|
2019 |
Kim SB, Fujii R, Nishihara R, Bose RJC, Citterio D, Suzuki K, Massoud TF, Paulmurugan R. Molecular imaging of retinoic acids in live cells using single-chain bioluminescence probes. Acs Combinatorial Science. PMID 31034200 DOI: 10.1021/Acscombsci.9B00035 |
0.475 |
|
2019 |
Babikir H, Afjei R, Paulmurugan R, Massoud T. EXTH-30. PRECEDING p53 STABILIZATION USING DOXORUBICIN AUGMENTS PRIMA-1-MEDIATED p53 REFOLDING AND INCREASED CELLULAR APOPTOSIS: EVALUATION OF A SEQUENTIAL COMBINATION THERAPY AGAINST GLIOBLASTOMA Neuro-Oncology. 21: vi88-vi88. DOI: 10.1093/Neuonc/Noz175.362 |
0.572 |
|
2019 |
Sukumar U, Afjei R, Massoud T, Paulmurugan R. EXTH-28. TARGETED POLYGIONS ENGINEERED WITH SURFACE miRNAs FOR COMBINED MULTIMODALITY IMAGING AND ENHANCEMENT OF TEMOZOLOMIDE TREATMENT: A NOVEL INTRANASALLY-DELIVERED THERANOSTIC STRATEGY AGAINST GLIOBLASTOMA Neuro-Oncology. 21: vi87-vi88. DOI: 10.1093/Neuonc/Noz175.360 |
0.632 |
|
2018 |
Kumar N, Afjei R, Massoud TF, Paulmurugan R. Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis. Scientific Reports. 8: 16363. PMID 30397244 DOI: 10.1038/S41598-018-34696-X |
0.508 |
|
2018 |
Jc Bose R, Uday Kumar S, Zeng Y, Afjei R, Robinson E, Lau K, Bermudez A, Habte F, Pitteri SJ, Sinclair R, Willmann JK, Massoud TF, Gambhir SS, Paulmurugan R. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents. Acs Nano. PMID 30346694 DOI: 10.1021/Acsnano.8B02587 |
0.771 |
|
2018 |
Babikir HA, Afjei R, Paulmurugan R, Massoud TF. Restoring guardianship of the genome: Anticancer drug strategies to reverse oncogenic mutant p53 misfolding. Cancer Treatment Reviews. 71: 19-31. PMID 30336366 DOI: 10.1016/J.Ctrv.2018.09.004 |
0.496 |
|
2018 |
Paulmurugan R, Afjei R, Sekar TV, Babikir HA, Massoud TF. A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells. Oncotarget. 9: 21495-21511. PMID 29765555 DOI: 10.18632/Oncotarget.25138 |
0.529 |
|
2018 |
Malhotra M, Sekar TV, Ananta JS, Devulapally R, Afjei R, Babikir HA, Paulmurugan R, Massoud TF. Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide and in a mouse model. Oncotarget. 9: 21478-21494. PMID 29765554 DOI: 10.18632/Oncotarget.25135 |
0.536 |
|
2017 |
Gaur S, Bhargava-Shah A, Hori S, Afjei R, Sekar TV, Gambhir SS, Massoud TF, Paulmurugan R. Engineering intracellularly retained Gaussia Luciferase reporters for improved biosensing and molecular imaging applications. Acs Chemical Biology. PMID 28767220 DOI: 10.1021/Acschembio.7B00454 |
0.786 |
|
2017 |
Malhotra M, Sekar T, Devulapally R, Afjei R, Paulmurugan R, Massoud T. EXTH-61. TARGETED NANOPARTICLE DELIVERY OF THERAPEUTIC ANTIMIR-21 AND ANTIMIR-10B PRESENSITIZES GLIOBLASTOMA TO LOWER EFFECTIVE DOSES OF TEMOZOLOMIDE IN CELLS AND XENOGRAFTS Neuro-Oncology. 19: vi86-vi86. DOI: 10.1093/Neuonc/Nox168.353 |
0.547 |
|
2017 |
Paulmurugan R, Afjei R, Babikir H, Sekar T, Massoud T. DDIS-16. A MOLECULAR IMAGING BIOSENSOR MONITORS THE EFFECTS OF ANTI-MISFOLDING DRUGS THAT RESTORE MUTANT p53 FUNCTION AND ENHANCE COMBINATION CHEMOTHERAPY FOR GLIOBLASTOMA Neuro-Oncology. 19: vi62-vi62. DOI: 10.1093/Neuonc/Nox168.251 |
0.563 |
|
2017 |
Johnson E, Murty S, Mayer A, Tsai C, Mehta S, Ilovich O, Massoud T, Andreasson K, James M. TMIC-30. TREM1-TARGETED PET IMAGING OF TUMOR-ASSOCIATED MACROPHAGES IN AN ORTHOTOPIC GLIOBLASTOMA MOUSE MODEL Neuro-Oncology. 19: vi249-vi249. DOI: 10.1093/Neuonc/Nox168.1019 |
0.747 |
|
2016 |
Sekar TV, Foygel K, Devulapally R, Kumar V, Malhotra S, Massoud TF, Paulmurugan R. Molecular Imaging Biosensor Monitors p53 Sumoylation in Cells and Living Mice. Analytical Chemistry. 88: 11420-11428. PMID 27934110 DOI: 10.1021/Acs.Analchem.6B02048 |
0.543 |
|
2016 |
Sekar TV, Foygel K, Massoud TF, Gambhir SS, Paulmurugan R. A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling. Scientific Reports. 6: 34788. PMID 27721470 DOI: 10.1038/Srep34788 |
0.592 |
|
2016 |
Ananta JS, Paulmurugan R, Massoud TF. Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a "Personalized" Anti-microRNA Therapy. Molecular Pharmaceutics. 13: 3164-75. PMID 27508339 DOI: 10.1021/Acs.Molpharmaceut.6B00388 |
0.479 |
|
2016 |
Sheahan AV, Sekar TV, Chen K, Paulmurugan R, Massoud TF. A molecular imaging biosensor detects in vivo protein folding and misfolding. Journal of Molecular Medicine (Berlin, Germany). PMID 27277823 DOI: 10.1007/S00109-016-1437-9 |
0.551 |
|
2016 |
Ananta JS, Paulmurugan R, Massoud TF. Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation. Neurological Research. 38: 51-9. PMID 26905383 DOI: 10.1080/01616412.2015.1133025 |
0.491 |
|
2015 |
Ananta JS, Paulmurugan R, Massoud TF. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells. Molecular Pharmaceutics. 12: 4509-17. PMID 26559642 DOI: 10.1021/Acs.Molpharmaceut.5B00694 |
0.494 |
|
2015 |
Paulmurugan R, Bhethanabotla R, Mishra K, Devulapally R, Foygel K, Sekar TV, Ananta JS, Massoud TF, Joy A. Folate Receptor Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple Negative Breast Cancer. Molecular Cancer Therapeutics. PMID 26553061 DOI: 10.1158/1535-7163.Mct-15-0579 |
0.548 |
|
2015 |
Devulapally R, Sekar NM, Sekar TV, Foygel K, Massoud TF, Willmann JK, Paulmurugan R. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. Acs Nano. 9: 2290-302. PMID 25652012 DOI: 10.1021/Nn507465D |
0.496 |
|
2013 |
Fan-Minogue H, Bodapati S, Solow-Cordero D, Fan A, Paulmurugan R, Massoud TF, Felsher DW, Gambhir SS. A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. Molecular Cancer Therapeutics. 12: 1896-905. PMID 23825064 DOI: 10.1158/1535-7163.Mct-12-1243 |
0.776 |
|
2012 |
Chan CT, Reeves RE, Geller R, Yaghoubi SS, Hoehne A, Solow-Cordero DE, Chiosis G, Massoud TF, Paulmurugan R, Gambhir SS. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. Proceedings of the National Academy of Sciences of the United States of America. 109: E2476-85. PMID 22895790 DOI: 10.1073/Pnas.1205459109 |
0.765 |
|
2012 |
Kijima N, Hosen N, Kagawa N, Hashimoto N, Chiba Y, Kinoshita M, Sugiyama H, Yoshimine T, Kim YZ, Kim KH, Lee EH, Hu B, Sim H, Mohan N, Agudelo-Garcia P, ... ... Massoud TF, et al. LAB-CELL BIOLOGY AND SIGNALING Neuro-Oncology. 14: vi7-vi20. DOI: 10.1093/Neuonc/Nos220 |
0.564 |
|
2011 |
Paulmurugan R, Tamrazi A, Massoud TF, Katzenellenbogen JA, Gambhir SS. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation. Molecular Endocrinology (Baltimore, Md.). 25: 2029-40. PMID 22052998 DOI: 10.1210/Me.2011-1145 |
0.567 |
|
2011 |
Dragulescu-Andrasi A, Chan CT, De A, Massoud TF, Gambhir SS. Bioluminescence resonance energy transfer (BRET) imaging of protein-protein interactions within deep tissues of living subjects. Proceedings of the National Academy of Sciences of the United States of America. 108: 12060-5. PMID 21730157 DOI: 10.1073/Pnas.1100923108 |
0.771 |
|
2011 |
Thakor AS, Luong R, Paulmurugan R, Lin FI, Kempen P, Zavaleta C, Chu P, Massoud TF, Sinclair R, Gambhir SS. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Science Translational Medicine. 3: 79ra33. PMID 21508310 DOI: 10.1126/Scitranslmed.3001963 |
0.755 |
|
2011 |
Thakor AS, Paulmurugan R, Kempen P, Zavaleta C, Sinclair R, Massoud TF, Gambhir SS. Oxidative stress mediates the effects of Raman-active gold nanoparticles in human cells. Small (Weinheim An Der Bergstrasse, Germany). 7: 126-36. PMID 21104804 DOI: 10.1002/Smll.201001466 |
0.767 |
|
2010 |
Fan-Minogue H, Cao Z, Paulmurugan R, Chan CT, Massoud TF, Felsher DW, Gambhir SS. Noninvasive molecular imaging of c-Myc activation in living mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 15892-7. PMID 20713710 DOI: 10.1073/Pnas.1007443107 |
0.771 |
|
2010 |
Massoud TF, Paulmurugan R, Gambhir SS. A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography. Nature Medicine. 16: 921-6. PMID 20639890 DOI: 10.1038/Nm.2185 |
0.628 |
|
2010 |
Massoud TF, Paulmurugan R, Chan C, Fan-Minogue H, Gambhir SS. Reporter gene imaging of cell signal transduction Molecular Imaging With Reporter Genes. 195-226. DOI: 10.1017/CBO9780511730405.009 |
0.756 |
|
2009 |
Thakor AS, Massoud T. Double superior vena cavae. Bmj Case Reports. 2009. PMID 21686460 DOI: 10.1136/Bcr.10.2008.1098 |
0.537 |
|
2009 |
Paulmurugan R, Padmanabhan P, Ahn BC, Ray S, Willmann JK, Massoud TF, Biswal S, Gambhir SS. A novel estrogen receptor intramolecular folding-based titratable transgene expression system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1703-11. PMID 19654568 DOI: 10.1038/Mt.2009.171 |
0.758 |
|
2008 |
Massoud TF, Singh A, Gambhir SS. Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications. Ajnr. American Journal of Neuroradiology. 29: 409-18. PMID 18272565 DOI: 10.3174/Ajnr.A0863 |
0.637 |
|
2008 |
Singh A, Massoud TF, Deroose C, Gambhir SS. Molecular imaging of reporter gene expression in prostate cancer: an overview. Seminars in Nuclear Medicine. 38: 9-19. PMID 18096460 DOI: 10.1053/J.Semnuclmed.2007.09.002 |
0.696 |
|
2008 |
Massoud TF, Singh A, Gambhir SS. Noninvasive molecular neuroimaging using reporter genes: part I, principles revisited. Ajnr. American Journal of Neuroradiology. 29: 229-34. PMID 18024575 DOI: 10.3174/Ajnr.A0864 |
0.636 |
|
2007 |
Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends in Molecular Medicine. 13: 183-91. PMID 17403616 DOI: 10.1016/J.Molmed.2007.03.003 |
0.402 |
|
2007 |
Massoud TF, Paulmurugan R, De A, Ray P, Gambhir SS. Reporter gene imaging of protein-protein interactions in living subjects. Current Opinion in Biotechnology. 18: 31-7. PMID 17254764 DOI: 10.1016/J.Copbio.2007.01.007 |
0.757 |
|
2004 |
Massoud TF, Paulmurugan R, Gambhir SS. Molecular imaging of homodimeric protein-protein interactions in living subjects. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1105-7. PMID 15132989 DOI: 10.1096/Fj.03-1128Fje |
0.634 |
|
2004 |
Paulmurugan R, Massoud TF, Huang J, Gambhir SS. Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Research. 64: 2113-9. PMID 15026351 DOI: 10.1158/0008-5472.Can-03-2972 |
0.628 |
|
2003 |
Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes & Development. 17: 545-80. PMID 12629038 DOI: 10.1101/Gad.1047403 |
0.327 |
|
Show low-probability matches. |